Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: theatrical (1), dramatic (4)

Routine pregnancy testing information for young people receiving systemic anti-cancer treatment (SACT) - patient information

Description: This factsheet contains information about routine pregnancy testing for young people receiving systemic anti-cancer treatment (SACT).
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Routine-pregnancy-testing-information-for-young-people-receiving-systemic-anti-cancer-treatment-SACT-3214-PIL.pdf

Lead for Imaging Research role JD

Description: UHS Lead for Imaging Research Job Role Version v2 28/02/2022 Job Title: Responsible to: Liaises with: Lead for Imaging
Url: /Media/Southampton-Clinical-Research/Downloads/Lead-for-Imaging-Research-role-JD.pdf

AMS FLIER summary 2022 - cohort 3 applications open

Description: Future Leaders in Innovation, Enterprise and Research (FLIER) Programme The Academy of Medical Sciences is pioneering a unique programme to develop
Url: /Media/Southampton-Clinical-Research/Grants/AMS-FLIER-summary-2022-cohort-3-applications-open.pdf

Erlotinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ERLOTINIB Regimen NSCLC - Erlotinib Indication Second line therapy of stage IIIB or IV
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Erlotinibver12.pdf

Gemcitabine

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEMCITABINE Regimen NSCLC - Gemcitabine Indication Second line therapy of stage III or IV
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gemcitabinever12.pdf

Enzalutamide

Description: Chemotherapy Protocol PROSTATE ENZALUTAMIDE Regimen • Prostate-Enzalutamide Indication • Enzalutamide is recommended within its marketing authorisation as an option for treating metastatic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Enzalutamide.pdf

Vinorelbine (intravenous)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Indication Second line therapy of stage III
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf

Chlorambucil Ver 1.1

Description: Chemotherapy Protocol LYMPHOMA CHLORAMBUCIL There are multiple versions of this protocol in use. Please ensure you have the correct protocol for
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Chlorambucil-Ver-1.1.pdf

Trastuzumab SC Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB SC Regimen Breast Cancer – Trastuzumab SC Indication Treatment of metastatic breast cancer over expressing HER2 - as
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-SC-Ver-1.1.pdf

(Refusing) Consent for surgery

Description: Two recent cases with similar facts have resulted in different outcomes.
Url: /HealthProfessionals/Clinical-law-updates/Refusing-Consent-for-surgery.aspx

191 to 200 of 368

Previous … 18 19 20 21 22 … Next